Shenyang Noah RongKang Biotechnology Pharmaceutical Co., Ltd. is a Sino-American joint pharmaceutical enterprise located in MedicineIndustrial Park in Shenyang Hunnan High-tech Development New District. 　　It was established on Oct. 25, 2004 with total investment of RMB 164 million yuan and registered capital of RMB 104.46 million yuan. The first phase project has passed national GMP certification and was put into operation in September 2005. It mainly engages in research, development and production of tablet, capsule,ointment and suppository of biotechnological products, natural medicines, traditional Chinese medicine and western medicine and health food as well as medical apparatus. Its main products are 6 kinds of State-level new drugs including three classic varieties, two sole patented varieties and one protected variety of Traditional Chinese Medicine. 　　In medicine field, natural medicines and bioengineering will be the key point of future development. The company has integral industrial structure chain combining research and development, production and sale. Its upper-stream research and development team can ensure that it has new products to be put into production every year and middle-stream production base has powerful production capacity to meet market demand, while the lower-stream sales network agencies and retail operation combining organically can make products enter market quickly. It has also had strong risk resistance. 　　Shenyang Noah RongKang Biotechnology Pharmaceutical Co., Ltd. introduced world top bioengineering technological project, which has gained the powerful support from the government. Besides the first phase project that has been put into normal production, the company will build research and development center, medium test base and No. 2 industrialized base to increase its assets’ value greatly and make its shareholders get return rapidly from their investment.